Brief: CEO And CFO Both To Leave Index Pharmaceuticals
March 26 (Reuters) - InDex Pharmaceuticals Holding AB
INDEX.ST :
* CEO AND CFO BOTH TO LEAVE INDEX PHARMACEUTICALS
* CEO JENNY SUNDQVIST AND CFO & DEPUTY CEO JOHAN GILÉUS WILL
LEAVE
COMPANY PER SEPTEMBER 26, 2024
Source text for Eikon: ID:nWkr43tQBQ
Further company coverage: INDEX.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Flerie AB
See all newsBrief: Flerie Q3 Net Asset Value SEK 3,113 Million
Brief: Flerie Portfolio Co Reports Positive Data From Clinical Proof-Of-Mechanism Study
Brief: Flerie Writes Down Value Of Holding In Empros Pharma
Brief: Nasdaq Approves Biosergen's Delisting Application
Brief: Flerie Approves Merger Plan For Flerie And Biosergen